Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Product containing risedronate sodium |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Risedronate sodium |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Risedronate sodium 5 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Risedronate sodium |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Risedronate sodium 30 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Risedronate sodium |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Risedronate sodium 35 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Risedronate sodium |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely risedronate sodium 75 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Risedronate sodium |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Calcium 500 mg and risedronate sodium 35 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Risedronate sodium |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Risedronate sodium 150 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Risedronate sodium |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely risedronate sodium 35 milligram/1 each gastro-resistant oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Risedronate sodium |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Risedronate sodium 5 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Risedronate sodium |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Risedronate sodium 5 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Risedronate sodium |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Risedronate sodium 30 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Risedronate sodium |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Risedronate sodium 30 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Risedronate sodium |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Risedronate sodium 35 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Risedronate sodium |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Risedronate sodium 35 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Risedronate sodium |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Calcium 500 mg and risedronate sodium 35 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Risedronate sodium |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Calcium 500 mg and risedronate sodium 35 mg oral tablet |
Has basis of strength substance (attribute) |
False |
Risedronate sodium |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely risedronate sodium 75 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Risedronate sodium |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely risedronate sodium 75 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Risedronate sodium |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Risedronate sodium 150 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Risedronate sodium |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Risedronate sodium 150 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Risedronate sodium |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Calcium 500 mg and risedronate sodium 35 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Risedronate sodium |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Risedronate sodium hemi-pentahydrate (substance) |
Is a |
False |
Risedronate sodium |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Risedronate sodium hemi-pentahydrate (substance) |
Is modification of (attribute) |
True |
Risedronate sodium |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Risedronate sodium 35 mg oral tablet |
Has precise active ingredient |
True |
Risedronate sodium |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Risedronate sodium 5 mg oral tablet |
Has precise active ingredient |
True |
Risedronate sodium |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Risedronate sodium 150 mg oral tablet |
Has precise active ingredient |
True |
Risedronate sodium |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Risedronate sodium 30 mg oral tablet |
Has precise active ingredient |
True |
Risedronate sodium |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely risedronate sodium 75 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Risedronate sodium |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Calcium 500 mg and risedronate sodium 35 mg oral tablet |
Has precise active ingredient |
True |
Risedronate sodium |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely risedronate sodium 35 milligram/1 each gastro-resistant oral tablet (clinical drug) |
Has precise active ingredient |
True |
Risedronate sodium |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely risedronate sodium 35 milligram/1 each gastro-resistant oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Risedronate sodium |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Risedronate sodium anhydrous (substance) |
Is modification of (attribute) |
True |
Risedronate sodium |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|